A phase 1b/2b multicenter study of oral panobinostat plus azacitidine in adults with MDS, CMML or AML with ⩽30% blasts

Overview of attention for article published in Leukemia, May 2017

Altmetric Badge

Mentioned by

twitter: 2 X users

Readers on

mendeley: 62 Mendeley

So far, Altmetric has seen 3 X posts from 2 X users, with an upper bound of 24,863 followers.

A phase 1b/2b study of oral panobinostat+azacitidine in adults w/MDS, CMML,or AML @garciamanero et al #MDSsm #leusm https://t.co/7xMXxe8XR8

RT @garciamanero: Our long study of azacitidine and panobinostat out in Leukemia https://t.co/25GkTtvAVH https://t.co/Q2r24VVPvH

Our long study of azacitidine and panobinostat out in Leukemia https://t.co/25GkTtvAVH https://t.co/Q2r24VVPvH

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.

Login to access the Sentiment Analysis related to this output.